Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03904069
Title Study Evaluating the Safety, Tolerability, and Efficacy of FLT3 CAR-T AMG 553 in FLT3-positive Relapsed/Refractory AML
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Amgen
Indications
Therapies
Age Groups: adult | senior | child
Covered Countries USA

Additional content available in CKB BOOST